aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in 2017, Ajax Health LLC is dedicated to providing capital and capabilities to develop and manufacture biotechnology drugs. The company's core mission is to support the innovation and advancement of medical technologies that save lives. Ajax Health focuses on the biotechnology and medical technology markets, offering financial backing and strategic guidance to emerging companies in these sectors.
Notable affiliates include investment giants KKR and Hellman & Friedman, who have led significant funding rounds for Ajax Health. Key achievements include raising $90 million for the establishment of Cortex, a comprehensive AFib ablation technology company. Ajax Health's impact is evident in its support for medtech innovation, extending its model to partnerships with major industry players like Hologic.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Biotech Drugs
Technology
Biotech
Tags
SaaS
Model Types
Recurring
Revenue Type(s)
Enterprise
Customer Type(s)
Global
When was Ajax Health founded?
Ajax Health was founded in 2017.
Where is Ajax Health's headquarters located?
Ajax Health's headquarters is located in Menlo Park, CA, US.
When was Ajax Health's last funding round?
Ajax Health's most recent funding round was for $15M (USD) in June 2019.
How many employees does Ajax Health have?
Ajax Health has 31 employees as of Feb 5, 2024.
How much has Ajax Health raised to-date?
As of July 05, 2023, Ajax Health has raised a total of $315M (USD) since Jun 18, 2019.
Add Comparison
Total Raised to Date
$315M
USD
Last Update Jun 18, 2019
Last Deal Details
$15M
USD
Jun 18, 2019
Series C
Total Employees Over Time
31
As of Feb 2024
Ajax Health Address
932 Santa Cruz Ave
suite c-1
Menlo Park,
California
94025
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts